Disease | angioedema |
Phenotype | C0019243|c1 inhibitor deficiency |
Sentences | 16 |
PubMedID- 25054967 | Context and objective: hereditary angioedema (hae) with c1 inhibitor deficiency manifests as recurrent episodes of edema involving the skin, upper respiratory tract and gastrointestinal tract. |
PubMedID- 23282382 | The prognosis for patients with acquired angioedema associated with c1 inhibitor deficiency is variable and depends on control of the underlying disorder. |
PubMedID- 26429506 | The safety of treatments for angioedema with hereditary c1 inhibitor deficiency. |
PubMedID- 24556385 | Methods: eleven patients (nine hae type 1, one hae type 2 and one acquired angioedema with c1 inhibitor deficiency) received between one and six, mostly self-administered, doses of rhc1inh for acute hae attacks. |
PubMedID- 25924832 | Background: attacks of hereditary angioedema with c1 inhibitor deficiency (c1-inh-hae) are commonly treated in the emergency department. |
PubMedID- 26154504 | Hereditary angioedema with c1 inhibitor deficiency (c1-inh-hae) is a rare autosomal dominant disease with an uncertain prevalence estimated to be 1: 50 000 [1] and is caused by mutation in the serping1 gene. |
PubMedID- 25538858 | In this review, we describe known mechanisms for the development of angioedema in patients with c1 inhibitor deficiency. |
PubMedID- 24054366 | Hereditary angioedema with c1 inhibitor deficiency: clinical presentation and quality of life of 193 french patients. |
PubMedID- 20804470 | Mutational spectrum and phenotypes in danish families with hereditary angioedema because of c1 inhibitor deficiency. |
PubMedID- 22230421 | Acquired angioedema with c1 inhibitor deficiency associated with anticardiolipin antibodies. |
PubMedID- 20859548 | Hereditary angioedema, resulting from inherited partial c1 inhibitor deficiency, is a disabling condition characterized by intermittent episodes of bradykinin-mediated angioedema. |
PubMedID- 23937903 | Hereditary angioedema with c1 inhibitor deficiency: delay in diagnosis in europe. |
PubMedID- 22909164 | Background: hereditary angioedema (hae) owing to c1 inhibitor deficiency is an autosomal dominant disorder, characterized by recurrent, potentially life-threatening, localized attacks of tissue swelling. |
PubMedID- 24970460 | Acquired angioedema with c1 inhibitor deficiency secondary to splenic marginal zone b-cell lymphoma. |
PubMedID- 21039598 | Standard care impact on angioedema because of hereditary c1 inhibitor deficiency: a 21-month prospective study in a cohort of 103 patients. |
PubMedID- 22126399 | Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary c1 inhibitor deficiency: consensus report of an international working group. |
Page: 1